Johnson & Johnson Forecasts 2024 Adjusted EPS Guidance Of $9.97–$10.07 Compared To Prior Guidance Of $10.57–$10.72 And Consensus Of $10.01
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has revised its 2024 adjusted EPS guidance to a range of $9.97–$10.07, down from the previous guidance of $10.57–$10.72 and slightly below the consensus estimate of $10.01.
July 17, 2024 | 10:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Johnson & Johnson has lowered its 2024 adjusted EPS guidance to $9.97–$10.07, down from the previous range of $10.57–$10.72 and below the consensus estimate of $10.01. This revision may indicate potential challenges ahead, which could negatively impact investor sentiment in the short term.
The downward revision of the EPS guidance suggests that Johnson & Johnson may be facing challenges that could affect its profitability. This is likely to result in negative investor sentiment and a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100